Skip to content
Tenfell
Awarded contract
Published 26 Nov 2025

BH_NonClinical_Pharmacy_Car-T

Barts Health NHS Trust · London

Key facts

Contract value
£2,100,000
Contract starts
08 Dec 2025
Contract ends
05 Dec 2030
Procedure
Direct award
Buyer type
Health

Awarded to

SupplierValue
Bristol Myers Squibb£2,100,000

Description

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.

Categories (CPV)

Similar open tenders

About Barts Health NHS Trust

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.